Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khursheed Anwer

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Formulations for DNA delivery via electroporation in vivoKhursheed Anwer
Critical Reviews in Therapeutic Drug Carrier Systems|November 26, 2003
Recent progress in polymeric gene delivery systemsKhursheed Anwer, B G Rhee, Sanjeev Kumar Mendiratta
Future Oncology (London, England)|October 17, 2018
GEN-1 immunotherapy for the treatment of ovarian cancerPremal H Thaker, Nicholas Borys, Jason Fewell, et al.
Gynecologic Oncology|July 19, 2013
Phase I trial of a formulated IL-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancerKhursheed Anwer, F Joseph Kelly, Christina Chu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 5, 2005
Synthesis and application of a non-viral gene delivery system for immunogene therapy of cancerJason G Fewell, Majed Matar, Gregory Slobodkin, et al.
Expert Opinion on Investigational Drugs|February 26, 2026
Potential of IMNN-001 in epithelial ovarian cancer: assessment of clinical findingsPremal H Thaker, Stacy R Lindborg, Ana Limon, et al.
The Journal of Gene Medicine|June 10, 2009
Treatment of disseminated ovarian cancer using nonviral interleukin-12 gene therapy delivered intraperitoneallyJason G Fewell, Majed M Matar, Jennifer S Rice, et al.
JCO Clinical Cancer Informatics|January 6, 2023
Historic Clinical Trial External Control Arm Provides Actionable GEN-1 Efficacy Estimate Before a Randomized TrialXiang Yin, Ruthanna Davi, Elizabeth B Lamont, et al.
Anti-Cancer Drugs|January 8, 2008
A safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental gliomaAdam M Sonabend, Simona Velicu, Ilya V Ulasov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2021
GEN-1 in Combination with Neoadjuvant Chemotherapy for Patients with Advanced Epithelial Ovarian Cancer: A Phase I Dose-escalation StudyPremal H Thaker, William H Bradley, Charles A Leath, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Formulations for DNA delivery via electroporation in vivoKhursheed Anwer
Critical Reviews in Therapeutic Drug Carrier Systems|November 26, 2003
Recent progress in polymeric gene delivery systemsKhursheed Anwer, B G Rhee, Sanjeev Kumar Mendiratta
Future Oncology (London, England)|October 17, 2018
GEN-1 immunotherapy for the treatment of ovarian cancerPremal H Thaker, Nicholas Borys, Jason Fewell, et al.
Gynecologic Oncology|July 19, 2013
Phase I trial of a formulated IL-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancerKhursheed Anwer, F Joseph Kelly, Christina Chu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 5, 2005
Synthesis and application of a non-viral gene delivery system for immunogene therapy of cancerJason G Fewell, Majed Matar, Gregory Slobodkin, et al.
Expert Opinion on Investigational Drugs|February 26, 2026
Potential of IMNN-001 in epithelial ovarian cancer: assessment of clinical findingsPremal H Thaker, Stacy R Lindborg, Ana Limon, et al.
The Journal of Gene Medicine|June 10, 2009
Treatment of disseminated ovarian cancer using nonviral interleukin-12 gene therapy delivered intraperitoneallyJason G Fewell, Majed M Matar, Jennifer S Rice, et al.
JCO Clinical Cancer Informatics|January 6, 2023
Historic Clinical Trial External Control Arm Provides Actionable GEN-1 Efficacy Estimate Before a Randomized TrialXiang Yin, Ruthanna Davi, Elizabeth B Lamont, et al.
Anti-Cancer Drugs|January 8, 2008
A safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental gliomaAdam M Sonabend, Simona Velicu, Ilya V Ulasov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2021
GEN-1 in Combination with Neoadjuvant Chemotherapy for Patients with Advanced Epithelial Ovarian Cancer: A Phase I Dose-escalation StudyPremal H Thaker, William H Bradley, Charles A Leath, et al.
Pageof 2